Medical Device Mergers & Acquisitions (M&A) Regulatory Services Seamless Regulatory Continuity During Corporate Transitions

Mergers, acquisitions, divestitures, and spin‑offs in the medical device industry introduce complex regulatory challenges. Ensuring uninterrupted compliance across markets requires careful integration of Quality Management Systems (QMS), regulatory documentation, registrations, technical files, clinical evidence, cybersecurity controls, and post‑market surveillance systems—all while maintaining business continuity.

Masuu Global Solutions provides specialized M&A regulatory services tailored for medical device and IVD manufacturers. Our experts support organizations through every stage of corporate transition by harmonizing processes, consolidating systems, and enabling smooth regulatory transfers in full alignment with ISO 13485, EU MDR/IVDR, FDA regulations, and global market requirements.

Medical Device M&A Compliance – Overview Medical device mergers involve:
  • Integrating two or more regulatory ecosystems
  • Assessing compliance maturity levels
  • Rationalizing product portfolios
  • Managing global submissions and license transfers
  • Aligning QMS and CAPA systems
  • Updating labeling, documentation, and PMS activities
  • Ensuring cybersecurity and data‑privacy compliance
  • Maintaining regulatory continuity in active markets
Masuu’s M&A regulatory services ensure that your organization meets all these obligations—reducing risks, preventing compliance gaps, and avoiding disruptions during corporate restructuring. Masuu’s Medical Device M&A Compliance Process Our structured M&A integration framework ensures end‑to‑end regulatory alignment: Regulatory Due Diligence
  • Comprehensive assessment of the target company’s regulatory health
  • Review of QMS maturity, technical documentation, labeling, clinical evidence, PMS systems, and global registrations
  • Risk identification and remediation planning
  • Verification of compliance liabilities and gaps
Regulatory Strategy & Planning
  • Integration roadmap for combined product portfolios
  • Market‑wise strategy for license transfer, renewals, and updates
  • Timeline planning for regulatory activities across 120+ markets
  • Prioritization of high‑impact submissions
QMS & CAPA Integration
  • Harmonization of QMS frameworks according to ISO 13485
  • Unification of CAPA systems, documentation, and governance
  • Internal audits & remediation for compliance gaps
  • Establishment of a consolidated QMS architecture
Regulatory Submissions & Registration Transfers
  • Preparation and submission of global regulatory filings
  • Handling certificate transfers, updates, amendments, and renewals
  • Direct communication with global Health Authorities and Notified Bodies
  • Ensuring zero disruption to market availability during transition
Data Privacy & Cybersecurity Integration
  • Assessment of data‑governance maturity and cybersecurity practices
  • Integration of privacy frameworks aligned with GDPR and global laws
  • Systems harmonization and data‑mapping for transferred records
  • Risk mitigation plan for cybersecurity vulnerabilities
Technical File Updates
  • Review and consolidation of technical documentation
  • Validation of design, manufacturing, labeling, and safety data
  • Updates to CERs, PERs, PMCF/PMPF deliverables, and clinical data packages
  • Ensuring continuous MDR/IVDR compliance during transition
Labeling Compliance
  • Updating labeling and IFUs to reflect new ownership
  • Harmonization of global labeling portfolios
  • Ensuring regional compliance across EU, US, UK, APAC, LATAM, and MEA
  • Artwork and UDI updates based on M&A changes
Post‑Market Surveillance (PMS) Integration
  • Merging PMS systems, databases, and vigilance workflows
  • Harmonizing adverse‑event reporting, trend analysis, and FSCA processes
  • Establishing unified PMS tech tools and communication structures
  • Maintaining uninterrupted safety monitoring
Global Registration Transfers
  • End‑to‑end coordination of product registration transfers
  • Liaising with regulatory authorities in 120+ countries
  • Maintaining certificates, approvals, and market access without interruption
Industry Challenges & How Masuu Solves Them
Industry Challenge Masuu’s Solution
Variability in QMS maturity across merging companies QMS harmonization, internal audits, gap analysis, and ISO 13485 alignment
Complex regulatory submission and registration transfers End‑to‑end submission management, SoMAD (Spin‑off/M&A/Divestiture) regulatory services
Labeling updates reflecting new corporate ownership Unified global labeling strategy, labeling remediation, and compliance updates
Managing clinical data, CERs, PERs & PMCF obligations Comprehensive clinical evaluation updates, PMCF integration, and evidence transfer
Cybersecurity & data‑privacy compliance gaps GDPR‑aligned assessments, cybersecurity integration plans, and data‑mapping
Combining disparate PMS systems Unified PMS platform, aligned reporting workflows, and consistent vigilance practices
What Masuu Does NOT Provide To maintain clarity and prevent overlap, Masuu’s M&A support does not include:
  • Legal M&A advisory
  • Financial or transactional consulting
  • Manufacturing or operational integration
Our focus is purely on regulatory, compliance, and quality integration—ensuring your organization remains continuously compliant during corporate change.
Book a Demo